Literature DB >> 7200404

Hormone receptors of the baboon cardiovascular system. Biochemical characterization of aortic and myocardial cytoplasmic progesterone receptors.

A L Lin, H C McGill, S A Shain.   

Abstract

We used the synthetic progestin R5020 (17 alpha, 21-dimethyl-19-norpregna-4,9-diene-3,20-dione) to characterize cytoplasmic progesterone receptors in baboon (Papio sp.) aorta and myocardium. The relative ability of selected steroids to inhibit binding of radiolabeled R5020 to aortic cytoplasmic progesterone receptors was radioinert R5020, 1.0; progesterone, 0.31; triamcinolone acetonide, 0.06; testosterone, 0.002; estradiol-17 beta, 0.01; and cortisol. 0.001. The relative ability of these same steroids to inhibit binding of radiolabeled R5020 to myocardial cytoplasmic progesterone receptors was, respectively, 1.0, 0.58, 0.21, 0.01, 0.01, and 0.001. Both aortic and myocardial cytoplasmic progesterone receptors migrated as macromolecules with a sedimentation coefficient of 8-9S on low ionic strength linear sucrose gradients. Cytoplasmic binding of R5020 was inactivated by incubation of 37 degrees C. Saturation analysis at 2 degrees C showed aorta and myocardium, respectively, contained 41.6 +/- 16.1 (mean +/- SD) and was 14.0 +/- 2.8 fmol R5020 binding sites/mg cytosol protein. The dissociation constant for R5020 was 2.8 +/- 1.2 nM, aorta, and 2.0 +/- 1.1 nM, myocardium. The presence of progesterone receptors in baboon cardiovascular tissues suggests that progestins may directly influence cardiovascular tissue function.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7200404     DOI: 10.1161/01.res.50.5.610

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  16 in total

1.  Inhibition of apoptosis by progesterone in cardiomyocytes.

Authors:  Stephen Morrissy; Beibei Xu; David Aguilar; Jack Zhang; Qin M Chen
Journal:  Aging Cell       Date:  2010-10       Impact factor: 9.304

2.  NAD(P)H:quinone oxidoreductase 1 is induced by progesterone in cardiomyocytes.

Authors:  Stephen Morrissy; Joshua Strom; Sally Purdom-Dickinson; Qin M Chen
Journal:  Cardiovasc Toxicol       Date:  2012-06       Impact factor: 3.231

Review 3.  Cardiovascular pharmacology of hormone replacement therapy.

Authors:  G M Rosano; G Panina
Journal:  Drugs Aging       Date:  1999-09       Impact factor: 3.923

Review 4.  Blood pressure and water regulation: understanding sex hormone effects within and between men and women.

Authors:  Megan M Wenner; Nina S Stachenfeld
Journal:  J Physiol       Date:  2012-10-01       Impact factor: 5.182

5.  Expression of glucocorticoid-induced leucine zipper (GILZ) in cardiomyocytes.

Authors:  David C Aguilar; Josh Strom; Beibei Xu; Kyle Kappeler; Qin M Chen
Journal:  Cardiovasc Toxicol       Date:  2013-06       Impact factor: 3.231

6.  Cardiovascular hemodynamics during stress in premenopausal versus postmenopausal women.

Authors:  Andrew Sherwood; Sat Byul Park; Joel W Hughes; James A Blumenthal; Alan Hinderliter; Ranak Trivedi; Judith McFetridge-Durdle
Journal:  Menopause       Date:  2010-03       Impact factor: 2.953

Review 7.  Transdermal estradiol/norethisterone. A review of its pharmacological properties and clinical use in postmenopausal women.

Authors:  L R Wiseman; D McTavish
Journal:  Drugs Aging       Date:  1994-03       Impact factor: 3.923

8.  Oestradiol inhibits smooth muscle cell proliferation of pig coronary artery.

Authors:  R Vargas; B Wroblewska; A Rego; J Hatch; P W Ramwell
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

9.  In vitro effect of oestradiol on thymidine uptake in pulmonary vascular smooth muscle cell: role of the endothelium.

Authors:  M Y Farhat; R Vargas; B Dingaan; P W Ramwell
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

10.  Stimulation of lysyl oxidase (EC 1.4.3.13) activity by testosterone and characterization of androgen receptors in cultured calf aorta smooth-muscle cells.

Authors:  R E Bronson; S D Calaman; A M Traish; H M Kagan
Journal:  Biochem J       Date:  1987-06-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.